Skip to main content
Premium Trial:

Request an Annual Quote

U.S. Genomics Names John Canepa as New CEO

NEW YORK, Dec. 15 (GenomeWeb News) - U.S. Genomics has promoted acting CEO John Canepa to president, chief executive officer, and a member of the board of directors, the company said today.


Canepa, formerly the company's chief financial officer, was appointed acting CEO in June when Stephen DeFalco left in July to become chief operating officer and chief executive of MDS.


Canepa will continue to lead the company in developing biodefense applications and the Trilogy 2020 platform and assays, the company said.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.